MARKHAM, ON, Nov. 26 /CNW/ - Andreas Krebs, President, Europe/Middle East/Africa and Canada, Wyeth Pharmaceuticals is pleased to announce the appointment of Christian Velmer to the position of President and Managing Director of Wyeth Canada effective November 17, 2008. Mr. Velmer replaces Arnout Ploos Van Amstel, who has taken a position as Senior Vice President and General Manager, Institutional Business Unit for Wyeth.
“Mr. Velmer brings to his new position an extensive knowledge of pharmaceutical company management. I’m pleased to welcome him aboard and I look forward to the continued progress of the Canadian business under his leadership,” said Mr. Krebs.
Most recently, Mr. Velmer was Senior Vice President Western Europe for Merck Serono in Frankfurt, Germany where he was responsible for the management of 16 countries across Europe. Prior to joining Merck Serono, Mr. Velmer held a series of progressive senior executive positions with Johnson & Johnson and Bayer in Europe, Asia Pacific and Latin America.
Wyeth is one of the world’s largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products, nutritionals and non-prescription medicines that improve the quality of life for people worldwide. Wyeth Canada is an affiliate of Wyeth, with more than 1,800 employees across the country. In Canada, Wyeth’s major divisions include Wyeth Pharmaceuticals, Wyeth Research, Wyeth Organics, Wyeth Animal Health and Wyeth Consumer Healthcare.
For further information
Media Contact: Lisa Ross, Wyeth Pharmaceuticals, (905) 470-3974
Source: Wyeth Canada/Wyeth Pharmaceuticals
